| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5876548 | The American Journal of Medicine | 2012 | 9 Pages |
Abstract
Use of warfarin at discharge in patients with atrial fibrillation is greater among those with higher stroke and bleeding risks, but despite higher-risk profiles, less than half received warfarin at discharge. These findings highlight that clarification is needed to guide choice of antithrombotic therapy for patients with both atrial fibrillation and acute myocardial infarction.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Renato D. MD, PhD, Li MS, Christopher B. MD, Tracy Y. MD, MHS, MSc, JoAnne M. MD, Marjorie PhD, RN, Eric D. MD, MPH, Karen P. MD,